Evidence map›Paper›PMID 34504809›Full record

ArticleFrontiers in cellular and infection microbiology2021

Characterization of Emerging Pathogens Carrying

Barbara Ghiglione, María Sol Haim, Pedro Penzotti, Florencia Brunetti, Gabriela D Amico González, José Di Conza, Roque Figueroa-Espinosa, Lidia Nuñez, María Tereza Pepe Razzolini, Bruna Fuga and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Co-harboringChina CDC weekly · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Clonal dissemination of highly virulentOne health (Amsterdam, Netherlands) · 2023
    Article
  10. Applied and environmental microbiology · 2022
    Article
  11. Article
  12. Article
  13. Novel insights related to the rise of KPC-producingFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Barbara GhiglioneLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
María Sol HaimLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Pedro PenzottiLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Florencia BrunettiLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Gabriela D Amico GonzálezLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
José Di ConzaLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Roque Figueroa-EspinosaLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Lidia NuñezFacultad de Farmacia y Bioquímica, Cátedra de Salud Pública e Higiene Ambiental, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
María Tereza Pepe RazzoliniDepartamento de Saúde Ambiental, Laboratório de Microbiologia Ambiental e Resistência Antimicrobiana - MicroRes, Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brazil.
Bruna FugaDepartamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Fernanda EspositoDepartamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Maximiliano Vander HordenIngeniería - Gerencia Técnica, Dirección de Saneamiento, Agua y Saneamientos Argentinos S.A. (AySA), Buenos Aires, Argentina.
Nilton LincopanDepartamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Gabriel GutkindLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Pablo PowerLaboratorio de Resistencia Bacteriana, Instituto de Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Milena DropaDepartamento de Saúde Ambiental, Laboratório de Microbiologia Ambiental e Resistência Antimicrobiana - MicroRes, Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brazil.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidade de São Paulo · BRUniversity of Buenos Aires · ARArgentine Water and Sanitation (Argentina) · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Untreated wastewater is a reservoir for multidrug-resistant bacteria, but its role in the spread of antibiotic resistance in the human population remains poorly investigated. In this study, we isolated a KPC-2-producing ST2787

Indexed as

beta-LactamasesSewageAnti-Bacterial AgentsArgentinaEnterobacterHumansKlebsiellaKlebsiella pneumoniaeMicrobial Sensitivity TestsPhylogenyPlasmidsAnti-Bacterial Agentsbeta-LactamasesSewageEnterobacter asburiaeIncP-6Klebsiella quasipneumoniaeKPC-2wastewater

Identifiers

PMID34504809
PMCPMC8421773
OpenAlexW3195220652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.